|
1
|
Hoogervorst LA, op de Coul LS, Ray A, de Witte PB, de Boer MGJ. Mycetoma caused by Madurella mycetomatis in immunocompromised patients – a case report and systematic literature review. J Bone Jt Infect 2022; 7:241-248. [DOI: 10.5194/jbji-7-241-2022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/26/2022] [Accepted: 11/10/2022] [Indexed: 11/22/2022] Open
Abstract
Abstract. The aim of this study was to review the available literature
concerning Madura foot (“mycetoma”) caused by Madurella mycetomatis in immunocompromised
patients. With a systematic literature search, we identified only three
papers, describing a total of three immunocompromised patients. Hence, the clinical presentation and prognosis of the disease in this patient
population have not yet been well described. In addition, we present a case from our institution, illustrating the complexity of the treatment of this
rare disease. Although very rare in non-endemic countries, we emphasize that
mycetoma should be included in the differential diagnoses of (immunocompromised) patients who have been residing in a geographical area
where the disease is endemic and presenting with soft tissue inflammation of
one of the extremities.
Collapse
|